Category Archives: (Sandbox Syndication Account) Health News (Master Feed)
US FDA delays decision on Bristol Myers-2seventy bio cancer therapy
(Reuters) - The U.S. Food and Drug Administration (FDA) will not make a decision on Bristol Myers Squibb and 2seventy bio's marketing application of their blood cancer therapy, Abecma, for earlier lin...
Nov 20, 2023
US to offer more free COVID tests nationwide
By Ahmed Aboulenein WASHINGTON (Reuters) - The U.S. government on Monday will start taking orders for another round of free COVID-19 tests for delivery across the country, a Department of Health and H...
Nov 20, 2023
Researchers return to Alzheimer’s vaccines, buoyed by recent drug success
By Julie Steenhuysen CHICAGO (Reuters) - Breakthrough Alzheimer's treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentiall...
Nov 20, 2023
Mother of autistic children lodges complaint over emissions from Sanofi’s Depakine drug plant -Le Monde
PARIS (Reuters) - The mother of two autistic children in France has lodged a legal complaint for endangering life after she suspected she was exposed to airborne emissions from Sanofi's Depakine epile...
Nov 20, 2023
S.Africa’s Astral Foods swings to loss on $109 million electricity, bird flu hit
(Reuters) - South Africa's biggest poultry producer Astral Foods swung to a full-year loss on Monday, as an ongoing electricity crisis and the country's worst bird flu outbreak cost the company 2 bill...
Nov 20, 2023
Wegovy craze was all the rage on Q3 earnings calls
By Bhanvi Satija and Savyata Mishra (Reuters) - Weight loss was the talk of this earnings season, making names such as Wegovy, Ozempic and Mounjaro the water-cooler discussion that companies across th...
Nov 20, 2023
Waste from Adidas, Walmart, other brands fuelling Cambodia brick kilns-report
By Clare Baldwin and Helen Reid (Reuters) - Waste from at least 19 international brands including Adidas and Walmart is being used to fuel kilns in brick factories in Cambodia, and some workers were f...
Nov 19, 2023
Bayer cancels asundexian phase III study program
(Reuters) - Germany's Bayer AG said on Sunday it is cancelling a phase III study program to investigate the efficacy and safety of asundexian, an oral Factor XIa (FXIa) inhibitor. The decision to stop...
Nov 19, 2023
Bayer ordered to pay $1.56 billion in latest US trial loss over Roundup weedkiller
By Tom Hals (Reuters) - A Missouri jury ordered Bayer to pay $1.56 billion to four plaintiffs who claimed the company's Roundup weedkiller caused injuries including cancer, a verdict that could intens...
Nov 19, 2023
What’s behind the scramble for semaglutide?
By Maggie Fick LONDON (Reuters) - Demand for a diabetes medicine called Ozempic is soaring as people take it to shed pounds, leading to shortages in countries including Britain, Germany, Belgium and t...
Nov 18, 2023
